Zitong Zhao

Zitong Zhao

Auto-generated profile, based on publicly available information

Zitong Zhao

Department of Anatomical Pathology, Singapore General Hospital, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
JYJoe Yeong
Joe Yeong
ZZZitong Zhao
Zitong Zhao
JLJeffrey Chun Tatt Lim
Jeffrey Chun Tatt Lim
HLHuihua Li
Huihua Li
ATAye Aye Thike
Aye Aye Thike
LKLi Yan Khor
Li Yan Khor
Background/aims: The programmed cell death receptor 1 (PD-1) checkpoint inhibitor, nivolumab, has been approved for the treatment of metastatic renal cell carcinoma (RCC). However, the understanding of the expression and distribution of PD ligand 1 (PD-L1) in the tumour immune microenvironment and its prognostic role in an Asian cohort is limited. Our group investigated PD-L1 protein expression in a cohort of Asian patients with RCC of mixed ethnicity, using two commercially available antibody clones. Methods: E1L3N and SP263 anti-PD-L1 clones were used to categorise RCCs of various histological subtypes, diagnosed at our institution between 1995 and 2008, into PD-L1-positive or PD-L1-negative groups, based on a 1% Tumour Proportion Score (TPS) cut-off. Results: In total, 267 (83%) clear cell (cc)RCC and 55 (17%) non-ccRCC cases were studied. Overall PD-L1 protein expression rates for the entire cohort were 13% and 8% for the E1L3N and SP263 clones, respectively. Patients bearing PD-L1-positive tumours experienced significantly decreased disease-free survival (DFS; E1L3N: p=0.01; SP263: p=0.03) but not overall survival, compared with those with PD-L1-negative tumours. Multivariate survival analysis further confirmed the results of the E1L3N clone (HR 1.85, 95% CI 1.10 to 3.13, p=0.02), but not SP263, after adjusting for pathological stage, histological subtype and grade. The addition of PD-L1 (E1L3N) TPS to clinicopathological features significantly increased the prognostic value for DFS (∆LRχ 2 =5.25; p=0.022), compared with clinicopathological features alone. Conclusions: PD-L1 protein expression was associated with an unfavourable prognosis in our study cohort. PD-L1 (E1L3N) expression was an independent prognostic indicator of clinical outcome in all RCCs when using a 1% cut-off.

31 May 2018 in Head and Neck Pathology
Verified
Journal Article
Closed access
PDF file
ZZZitong Zhao
Zitong Zhao
YLYu Jin Lee
Yu Jin Lee
SZShuwei Zheng
Shuwei Zheng
LKLi Yan Khor
Li Yan Khor
KLKok Hing Lim
Kok Hing Lim

1 November 2018 in Human Pathology: Case Reports
Verified
Journal Article
Open access
PDF file
ZZZitong Zhao
Zitong Zhao
TTTimothy Kwang Yong Tay
Timothy Kwang Yong Tay
RARashi Agrawal
Rashi Agrawal
VTVeronique Kiak Mien Tan
Veronique Kiak Mien Tan
YTYah Yuen Tan
Yah Yuen Tan
PTPuay Hoon Tan
Puay Hoon Tan
Paget's disease was first described by James Paget in 1874, as a neoplastic condition that exclusively affects the nipple areolar complex (NAC) from which it may spread to the surrounding skin [ 1 1 ]. It comprises approximately 2% of all cases of breast carcinoma, often associated with an underlying high grade disease with multifocality [ 2 2 ]. It is clinically characterized by eczematoid changes of the nipple. The most common cause of Paget's disease in the breast is in-situ or invasive carcinoma extending from the breast into the epidermis of the NAC.

17 February 2022 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
ZZZitong Zhao
Zitong Zhao
MKMark Jean Aan Koh
Mark Jean Aan Koh

8 December 2021 in Pathology International
Verified
Journal Article
Closed access
PDF file
ZZZitong Zhao
Zitong Zhao
ACAlicia Xue Fen Chia
Alicia Xue Fen Chia
YCYeow Leng Chua
Yeow Leng Chua
BTBan Hock Tan
Ban Hock Tan
SLSiang Hui Lai
Siang Hui Lai

14 April 2025 in Pathology International
Verified
Journal Article
Closed access
ZZZitong Zhao
Zitong Zhao
TTTimothy Kwang Yong Tay
Timothy Kwang Yong Tay
TLTony Kiat Hon Lim
Tony Kiat Hon Lim
LTLiang Seah Tay
Liang Seah Tay
GTGek San Tan
Gek San Tan
SWShing Lih Wong
Shing Lih Wong